As the fall season approaches, health officials are encouraging vaccinations against influenza, COVID-19, and respiratory syncytial virus (RSV) amid rising infection rates nationwide, although current levels remain low in Massachusetts and across the United States. Data from the Centers for Disease Control and Prevention (CDC) dated September 11 indicate that while illness rates are still minimal, they have begun to increase in several regions.

Sabrina Assoumou, an infectious disease physician at Boston Medical Center and professor at Boston University, highlighted the heightened risk of respiratory infections during colder months. "Especially here in the Northeast, because it gets so cold, this is a season when we tend to spend more time indoors compared to other regions," Assoumou explained. She emphasized that indoor environments, particularly those with limited ventilation, can facilitate the spread of airborne illnesses. Assoumou also played a role in Boston’s coordinated response to the COVID-19 pandemic.

This year’s vaccination campaign comes amid a reduction in federal guidance. The CDC’s advisory committee, which typically issues detailed recommendations on vaccine use, has been hindered by ongoing legal disputes stemming from policy changes initiated during the Trump administration. Those changes involved the rollback of several longstanding vaccine guidelines, creating uncertainty for health officials and providers regarding best practices for immunization strategies.

Despite the decreased federal direction, public health experts continue to advise that immunization against common respiratory illnesses remain a key preventative measure as cooler weather encourages indoor gatherings. Vaccines against influenza, COVID-19, and RSV are available this fall to help reduce the risk of outbreaks and severe illness during the traditional respiratory virus season.